Cerity Partners LLC

Position in FATE — Fate Therapeutics Inc

CIK 1566475 NEW YORK, NY

Position in FATE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$922,674

+$786,423 QoQ

Shares Held

341,732

+201.0% QoQ

Ownership

0.285%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#31

of 156 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 73% Shared 9% None 18%

Healthcare · as of Jun 30, 2026

Cerity Partners LLC holds $426,228,183 across 139 Biotechnology names. FATE ranks #38 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	255,874	$127,100,291
2	CORT	Corcept Therapeutics Inc	797,119	$69,309,495
3	HALO	Halozyme Therapeutics, Inc.	343,589	$26,892,710
4	REGN	Regeneron Pharmaceuticals, Inc.	39,274	$24,488,909
5	INCY	Incyte Corp	205,071	$23,246,847
6	EXEL	Exelixis, Inc.	377,130	$20,519,642
7	JAZZ	Jazz Pharmaceuticals plc	53,534	$12,900,087
8	RPRX	Royalty Pharma plc	180,772	$10,135,884

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$922,674	341,732	+201.0%	Shares	Defined	2026-08-14
2026-03-31	$136,251	113,544	+116.3%	Shares	Sole	2026-05-15
2025-12-31	$51,438	52,489	+3.3%	Shares	Sole	2026-02-11
2025-09-30	$64,029	50,817	+63.9%	Shares	Other	2025-10-22
2025-06-30	$34,727	31,007	+3.7%	Shares	Sole	2025-08-13
2025-03-31	$23,624	29,904	-96.4%	Shares	Sole	2025-04-30
2024-12-31	$28,206	823,134	+4953.6%	Shares	Sole	2025-02-13
2024-09-30	$57,008	16,288	+1.7%	Shares	Sole	2024-11-12
2024-06-30	$52,532	16,016	-4.7%	Shares	Sole	2024-08-13
2024-03-31	$123,356	16,806	-47.8%	Shares	Sole	2024-05-14
2023-12-31	$120,330	32,174	+0.7%	Shares	Sole	2024-01-26
2023-06-30	$152,082	31,950	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.